Your browser doesn't support javascript.
loading
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status.
Chowdhury, Apu; Sajid, Muhammad; Jahan, Nabila; Adelusi, Temitope Isaac; Maitra, Pulak; Yin, Guolian; Wu, Xudong; Gao, Yuan; Wang, Sicen.
Afiliação
  • Chowdhury A; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Sajid M; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Jahan N; School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
  • Adelusi TI; Computational Biology/Drug Discovery Laboratory, Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
  • Maitra P; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Yin G; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Wu X; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Gao Y; Faculty of Materials and Chemical Engineering, Yibin University, Yibin, Sichuan 644000, China.
  • Wang S; School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Electronic address: wangsc@mail.xjtu.edu.cn.
Biomed Pharmacother ; 142: 111956, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34332377

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabidiol / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabidiol / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article